v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net loss $ (12,486,450) $ (15,293,527)
Adjustments to reconcile net loss to net cash used in operating activities    
Change in fair value of warrant liabilities (72,320) (656,450)
Stock-based compensation expense 1,314,396 728,068
Changes in operating assets and liabilities:    
Prepaid clinical trial costs (current and non-current) 436,154 (1,270,373)
Prepaid expenses and other current assets 319,471 (271,189)
Accounts payable (1,535,859) 844,252
Accrued expenses and other current liabilities (1,182,338) (4,282,778)
Net cash used in operating activities (13,206,946) (20,201,997)
Cash flows from financing activities    
Proceeds from issuance of short-term debt 0 415,000
Repayment of short-term debt (344,908) (207,500)
Proceeds from issuance of common stock, common stock warrants, prefunded warrants and from modification of existing warrants, in offerings, net of transaction costs 9,210,000 2,805,221
Net cash provided by financing activities 10,094,329 3,012,721
Net decrease in cash and cash equivalents (3,112,617) (17,189,276)
Cash and cash equivalents, beginning of period 13,476,331 23,367,456
Cash and cash equivalents, end of period 10,363,714 6,178,180
Supplemental disclosures of cash flow information:    
Cash paid for taxes 3,369 3,417
Cash paid for interest 14,224 8,640
Noncash Investing and Financing Activities:    
Warrant modification recorded in stockholders' equity (deficit) 0 229,050
Transaction costs related to offerings included in accounts payable and accrued expenses 538,902 0
Common Stock Warrants [Member]    
Cash flows from financing activities    
Proceeds from exercise of common stock warrants 241,125 0
Noncash Investing and Financing Activities:    
Issuance of common stock warrants 5,070,661 1,081,689
The Market Offering Agreement "ATM Agreement" [Member]    
Cash flows from financing activities    
Proceeds from issuance of common stock in ATM offering, net of transaction costs $ 988,112 $ 0